Price Alert

Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

77.44

4.40 (6.02%)

At close: Sep 25, 2025, 3:59 PM

77.50

0.08%

After-hours: Sep 25, 2025, 05:19 PM EDT

6.02% (1D)

Bid	70
Market Cap	477.8M
Revenue (ttm)	n/a
Net Income (ttm)	-1.32B
EPS (ttm)	-3.84
PE Ratio (ttm)	-20.17
Forward PE	-18.33
Analyst	Buy
Dividends	n/a

Ask	80
Volume	66,492
Avg. Volume (20D)	51,076
Open	74.88
Previous Close	73.04
Day's Range	68.16 - 79.80
52-Week Range	4.50 - 80.00
Beta	1.22
Ex-Dividend Date	n/a

About MNPR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MNPR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MNPR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+14.55%

Monopar Therapeutics shares are trading higher aft... Unlock content with Pro Subscription

3 months ago

+7%

Monopar Therapeutics shares are trading higher after the company announced it will join the Russell 3000 index.

News

1 week ago · investors.com

Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout

Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.

3 weeks ago · seekingalpha.com

Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent

Monopar Therapeutics Inc. is a clinical-stage biotech with two promising programs: ALXN1840 for Wilson disease and a radiopharmaceuticals pipeline targeting advanced cancers. ALXN1840 has shown superi...